Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system

Thyroid

Volumn 25, Issue 6, 2015, Pages 698-705

  Lo, Joan C ^a,b   Rivkees, Scott A ^c   Chandra, Malini ^a   Gonzalez, Joel R ^a   Korelitz, James J ^d   Kuzniewicz, Michael W ^a,b  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; PROPYLTHIOURACIL; THIAMAZOLE;

ADOLESCENT; ADULT; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; CLUBFOOT; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG USE; FEMALE; GESTATIONAL THYROTOXICOSIS; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPOSPADIAS; INFANT; INTEGRATED HEALTH CARE SYSTEM; JEJUNAL ATRESIA; LARYNGOMALACIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; NEWBORN INTENSIVE CARE; PATENT URACHUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; PYLORUS STENOSIS; RISK ASSESSMENT; SYNDACTYLY; THYROTOXICOSIS; TREATMENT OUTCOME; CHEMICAL AND DRUG INDUCED LIVER INJURY; COHORT ANALYSIS; CONGENITAL ABNORMALITIES; NEONATAL INTENSIVE CARE UNIT; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; UTILIZATION; YOUNG ADULT;

ADULT; ANTITHYROID AGENTS; CHEMICAL AND DRUG INDUCED LIVER INJURY; COHORT STUDIES; CONGENITAL ABNORMALITIES; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; METHIMAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PREVALENCE; PROPYLTHIOURACIL; THYROTOXICOSIS; YOUNG ADULT;

EID: 84930535951     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0434     Document Type: Article

References (43)

1. Burrow GN 1993 Thyroid function and hyperfunction during gestation. Endocr Rev 14:194-202.
2. Galofre JC, Davies TF 2009 Autoimmune thyroid disease in pregnancy: a review. J Womens Health (Larchmt) 18:1847-1856.
3. Negro R, Mestman JH 2011 Thyroid disease in pregnancy. Best Pract Res Clin Endocrinol Metab 25:927-943.
4. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W 2011 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21:1081-1125.
5. Korelitz JJ, McNally DL, Masters MN, Li SX, Xu Y, Rivkees SA 2013 Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid 23:758-765.
6. Glinoer D 1998 Thyroid hyperfunction during pregnancy. Thyroid 8:859-864.
7. Lockwood CM, Grenache DG, Gronowski AM 2009 Serum human chorionic gonadotropin concentrations greater than 400, 000 IU/L are invariably associated with suppressed serum thyrotropin concentrations. Thyroid 19: 863-868.
8. Rodien P, Jordan N, Lefevre A, Royer J, Vasseur C, Savagner F, Bourdelot A, Rohmer V 2004 Abnormal stimulation of the thyrotrophin receptor during gestation. Hum Reprod Update 10:95-105.
9. Kimura M, Amino N, Tamaki H, Ito E, Mitsuda N, Miyai K, Tanizawa O 1993 Gestational thyrotoxicosis and hyperemesis gravidarum: possible role of hCG with higher stimulating activity. Clin Endocrinol 38:345-350.
10. Hershman JM 1999 Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. Thyroid 9:653-657.
11. Chan L 2003 Gestational transient thyrotoxicosis. Am J Emerg Med. 21:506.
12. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A 2007 Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92:S1-S47.
13. Barbero P, Valdez R, Rodriguez H, Tiscornia C, Mansilla E, Allons A, Coll S, Liascovich R 2008 Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 146A:2390-2395.
14. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R 1999 Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 83:43-46.
15. Di Gianantonio E, Schaefer C, Mastroiacovo PP, Cournot MP, Benedicenti F, Reuvers M, Occupati B, Robert E, Bellemin B, Addis A, Arnon J, Clementi M 2001 Adverse effects of prenatal methimazole exposure. Teratology 64:262-266.
16. Rivkees SA, Mandel SJ 2011 Thyroid disease in pregnancy. Horm Res Paediatr 76(Suppl 1):91-96.
17. Rivkees SA, Mattison DR 2009 Ending propylthiouracilinduced liver failure in children. N Engl J Med 360:1574-1575.
18. Rivkees SA, Mattison DR 2009 Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol 2009:132041.
19. Sequeira E, Wanyonyi S, Dodia R 2011 Severe propylthiouracil-induced hepatotoxicity in pregnancy managed successfully by liver transplantation: a case report. J Med Case Rep 5:461.
20. Hayashida CY, Duarte AJ, Sato AE, Yamashiro-Kanashiro EH 1990 Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil. J Endocrinol Invest 13:937-941.
21. Rivkees SA 2010 63 years and 715 days to the "boxed warning": unmasking of the propylthiouracil problem. Int J Pediatr Endocrinol 2010:658267.
22. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN 2011 Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 17:456-520.
23. Cooper DS 2005 Antithyroid drugs. N Engl J Med 352:905-917.
24. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, Eastman CJ, Lazarus JH, Luton D, Mandel SJ, Mestman J, Rovet J, Sullivan S 2012 Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97:2543-2565.
25. Lo JC, Feigenbaum SL, Escobar GJ, Yang J, Crites YM, Ferrara A 2006 Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care 29:1915-1917.
26. Escobar GJ, Fischer A, Kremers R, Usatin MS, Macedo AM, Gardner MN 1997 Rapid retrieval of neonatal outcomes data: the Kaiser Permanente Neonatal Minimum Data Set. Qual Manag Health Care 5:19-33.
27. Wilson A, Gardner MN, Armstrong MA, Folck BF, Escobar GJ 2000 Neonatal assisted ventilation: predictors, frequency, and duration in a mature managed care organization. Pediatrics 105:822-830.
28. Fenton TR 2003 A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 3:13.
29. Fenton TR, Sauve RS 2007 Using the LMS method to calculate z-scores for the Fenton preterm infant growth chart. Eur J Clin Nutr 61:1380-1385.
30. McLeod DS, Caturegli P, Cooper DS, Matos PG, Hutfless S 2014 Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA 311:1563-1565.
31. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG 1989 Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160:63-70.
32. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH 1994 Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84:946-949.
33. Momotani N, Ito K 1991 Treatment of pregnant patients with Basedow's disease. Exp Clin Endocrinol 97: 268-274.
34. Barbero P, Ricagni C, Mercado G, Bronberg R, Torrado M 2004 Choanal atresia associated with prenatal methimazole exposure: three new patients. Am J Med Genet A 129A: 83-86.
35. Bournaud C, Orgiazzi J 2003 Antithyroid agents and embryopathies [in French]. Ann Endocrinol (Paris) 64:366-369.
36. Wolf D, Foulds N, Daya H 2006 Antenatal carbimazole and choanal atresia: a new embryopathy. Arch Otolaryngol Head Neck Surg. 132:1009-1011.
37. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS, Correa A 2010 Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88: 1008-1016.
38. Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K, Kosuga Y, Suzuki M, Matsumoto M, Kunii Y, Watanabe N, Mukasa K, Ito K 2012 Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 97:2396-2403.
39. Gurlek A, Cobankara V, Bayraktar M 1997 Liver tests in hyperthyroidism: effect of antithyroid therapy. J Clin Gastroenterol 24:180-183.
40. Liaw YF, Huang MJ, Fan KD, Li KL, Wu SS, Chen TJ 1993 Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med 118:424-428.
41. Yoshihara A, Noh JY, Watanabe N, Iwaku K, Kobayashi S, Suzuki M, Ohye H, Matsumoto M, Kunii Y, Mukasa K, Sugino K, Ito K 2014 Frequency of adverse events of antithyroid drugs administered during pregnancy. J Thyroid Res 2014:952352.
42. Otsuka F, Noh JY, Chino T, Shimizu T, Mukasa K, Ito K, Taniyama M 2012 Hepatotoxicity and cutaneous reactions after antithyroid drug administration. Clin Endocrinol 77:310-315.
43. Laurberg P, Andersen SL 2014 Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk? Eur J Endocrinol 171:R13-R20